<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>As filed with the Securities and Exchange Commission on April&nbsp;11, 2011</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 0pt"><B>Registration No.&nbsp;333-</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 10pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 10pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 10pt"><B>REGISTRATION STATEMENT<BR>
UNDER THE SECURITIES ACT OF 1933</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 10pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 10pt"><B>VERINT SYSTEMS INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">
(Exact name of registrant as specified in its charter)</DIV>

<DIV align="center" style="font-size: 10pt">
<DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>11-3200514</B><BR>
(I.R.S. Employer Identification No.)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>330 South Service Road, Melville, New York</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>11747</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VERINT SYSTEMS INC. 2004 STOCK INCENTIVE COMPENSATION PLAN<BR>
WITNESS SYSTEMS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN</B><BR>
(Full title of the plan)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Peter Fante, Esq.<BR>
Chief Legal Officer<BR>
Verint Systems Inc.<BR>
330 South Service Road<BR>
Melville, New York 11747</B><BR>
(Name and address of agent for service)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>(631)&nbsp;962-9600</B><BR>
(Telephone number, including area code, of agent for service)
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 10pt"><B><I>With copies to:</I></B><BR>
Randi C. Lesnick, Esq.<BR>
Jones Day<BR>
222 East 41<SUP style="FONT-size: 85%; vertical-align: text-top">st</SUP> Street<BR>
New York, New York 10017<BR>
(212)&nbsp;326-3939
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act.
(Check one):
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Large accelerated filer&nbsp;<FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD nowrap>&nbsp;</TD>
    <TD align="center" valign="top">Accelerated
filer&nbsp;<FONT face="Wingdings">&#254;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Non-accelerated filer&nbsp;<FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Smaller reporting company&nbsp;<FONT face="Wingdings">&#111;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>


    <TD colspan="5" nowrap  align="center" valign="top">(Do not check if a smaller reporting company)</TD>


</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CALCULATION OF REGISTRATION FEE</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="41%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Proposed Maximum</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Proposed Maximum</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left">Title of Securities to be</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount to be</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Offering Price Per</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Aggregate Offering</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount of</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left">Registered</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Registered<SUP style="FONT-size: 85%; vertical-align: text-top">(1)(2)</SUP></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Share<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Price<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Registration Fee</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, $0.001 par
value per share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 2px solid #000000">35,815</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" style="border-top: 2px solid #000000">36.545</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 2px solid #000000">$</TD>
    <TD align="right" style="border-top: 2px solid #000000">1,308,859.18</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>


<TD colspan="3" align="center" style="border-top: 2px solid #000000">$151.96</TD>

    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96%">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: left">Pursuant to Rule&nbsp;416 under the Securities Act of 1933 (the &#147;Securities Act&#148;), this
Registration Statement shall include any additional shares of common stock, par value $0.001
per share (the &#147;Common Stock&#148;), that may become issuable as a result of stock splits, stock
dividends or similar transactions.</DIV></TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: left">Represents 21,760 shares of Common Stock previously issued pursuant to the Verint Systems
Inc. 2004 Stock Incentive Compensation Plan, as amended, to be registered for resale and
14,055 shares of Common Stock previously issued pursuant to the Witness Systems, Inc. Amended
and Restated Stock Incentive Plan, as amended, to be registered for resale. The Common Stock
has been previously issued to employees.</DIV></TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: left">Estimated solely for the purpose of calculating the amount of the registration fee pursuant
to Rule 457(c) under the Securities Act, based on the average of the high and low prices of
our Common Stock as reported by the NASDAQ Global Market on April&nbsp;5, 2011.</DIV></TD>
</TR>

</TABLE>



<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>






<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">





<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPLANATORY NOTE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">This Registration Statement contains two parts. The first part contains a resale prospectus
prepared in accordance with the requirements of General Instruction C to Form S-8 that covers
resales of &#147;restricted securities&#148; and &#147;control securities&#148; (in each case, as defined in General
Instruction C to Form S-8). This resale prospectus relates to shares of common stock, $0.001 par
value per share, of Verint Systems Inc. (the &#147;Company&#148;) previously issued to certain employees of
the Company pursuant to the Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as amended,
and the Witness Systems, Inc. Amended and Restated Stock Incentive Plan, as amended. The second
part of this Registration Statement contains Information Required in the Registration Statement
pursuant to Part&nbsp;II of Form S-8.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">




<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>REOFFER PROSPECTUS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VERINT SYSTEMS INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>35,815 SHARES OF COMMON STOCK</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">This prospectus relates to the resale, from time to time, of up to 35,815 shares of our common
stock, $0.001 par value per share, by the selling stockholders listed in this prospectus. The
selling stockholders acquired such shares pursuant to grants made under (1)&nbsp;the Verint Systems Inc.
2004 Stock Incentive Compensation Plan, as amended, and (2)&nbsp;the Witness Systems, Inc. Amended and
Restated Stock Incentive Plan, as amended. The Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended, and the Witness Systems, Inc. Amended and Restated Stock Incentive
Plan, as amended, are collectively referred to in this prospectus as the &#147;Plans.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The shares may be offered, from time to time, by
any or all of the selling stockholders through ordinary brokerage transactions, in negotiated
transactions or in other transactions, at such prices as he, she or they may determine, which may
relate to market prices prevailing at the time of sale or be a negotiated price. See &#147;Plan of
Distribution.&#148; We will bear all costs, expenses and fees in connection with the registration of
the shares. Brokerage commissions and similar selling expenses, if any, attributable to the offer
or sale of the shares will be borne by the selling stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Each selling stockholder and any broker executing selling orders on behalf of a selling
stockholder may be deemed to be an &#147;underwriter&#148; as defined in the Securities Act of 1933, as
amended, or the Securities Act. If any broker-dealers are used to effect sales, any commissions
paid to broker-dealers and, if broker-dealers purchase any of the shares of common stock covered by
this prospectus as principals, any profits received by such broker-dealers on the resales of shares
may be deemed to be underwriting discounts or commissions under the Securities Act. In addition,
any profits realized by the selling stockholders may be deemed to be underwriting commissions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Shares of our common stock are listed on the NASDAQ Global Market under the symbol &#147;VRNT.&#148; On
April&nbsp;8, 2011, the last reported sale price of our common stock was $36.70 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Investing in shares of our common stock involves a high degree of risk. See &#147;Risk Factors&#148; on
page 4 of this prospectus and the other risk factors set forth in our periodic and other filings
with the Securities and Exchange Commission, or the SEC, including those set forth in our Annual
Report on Form 10-K for the year ended January&nbsp;31, 2011, for a discussion of certain factors that
should carefully be considered by prospective purchasers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Neither the SEC nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">This prospectus is dated April&nbsp;11, 2011.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="C15401tocpage"></A>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="86%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401101">Prospectus Summary</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401102">Cautionary Note on Forward-Looking Statements</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401103">Risk Factors</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401104">Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401105">Selling Stockholders</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401106">Plan of Distribution</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401107">Legal Matters</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401108">Experts</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401109">Information Incorporated by Reference</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#C15401110">Where You Can Find Additional Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="c15401exv5w1.htm">EX-5.1</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="c15401exv23w1.htm">EX-23.1</A></FONT></TD></TR>
</TABLE>
</DIV>
<DIV align="left">
<!-- /TOC -->
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">You should rely only on the information contained in or incorporated by reference into this
prospectus. We have not authorized any other person to provide you with additional information or
information different from that contained in or incorporated by reference into this prospectus.
The selling stockholders may, from time to time, offer to sell shares of our common stock only in
jurisdictions where the offer or sale is permitted. You should not assume that the information
contained in this prospectus is accurate as of any date other than the date on the front cover of
this prospectus or that the information contained in any document incorporated by reference into
this prospectus is accurate as of any date other than the date of the document incorporated by
reference.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->i<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">



<DIV align="left">
<A name="C15401101"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PROSPECTUS SUMMARY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><I>This summary highlights information contained elsewhere in or incorporated by reference into
this prospectus. This summary is not complete and does not contain all of the information that may
be important to you and that you should consider before investing in shares of our common stock.
You should carefully read the entire prospectus, including the section titled &#147;Risk Factors,&#148; and
the other information incorporated by reference into this prospectus before making an investment
decision.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><I>References in this prospectus to the terms &#147;Verint,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our,&#148; or
other similar terms, mean Verint Systems Inc., together with its consolidated subsidiaries, unless
the context indicates otherwise.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VERINT SYSTEMS INC.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Verint is a global leader in Actionable Intelligence<SUP style="FONT-size: 85%; vertical-align: text-top">&#174;</SUP> solutions and value-added services. Our
solutions enable organizations of all sizes to make timely and effective decisions to improve
enterprise performance and make the world a safer place. More than 10,000 organizations in over
150 countries&#151;including over 85% of the Fortune 100&#151;use Verint Actionable Intelligence solutions
to capture, distill, and analyze complex and underused information sources, such as voice, video,
and unstructured text.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">In the enterprise market, our workforce optimization solutions help organizations enhance
customer service operations in contact centers, branches, and back-office environments to increase
customer satisfaction, reduce operating costs, identify revenue opportunities, and improve
profitability. In the security intelligence market, our video intelligence, public safety, and
communications intelligence solutions are vital to government and commercial organizations in their
efforts to protect people and property and neutralize terrorism and crime.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We have established leadership positions in both the enterprise workforce optimization and
security intelligence markets by leveraging our core competency in developing highly scalable,
enterprise-class applications with advanced, integrated analytics for both unstructured and
structured information. Our innovative solutions are developed by approximately 900 employees and
contractors in research and development, representing approximately one-third of our total
headcount, and are evidenced by more than 500 patents and patent applications worldwide. We offer
a range of customer services, from initial implementation to ongoing maintenance and support, to
maximize the value our customers receive from our Actionable Intelligence solutions and to allow us
to extend our customer relationships.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Our principal executive offices are located at 330 South Service Road, Melville, New York
11747. Our telephone number at that address is (631)&nbsp;962-9600. Our website is www.verint.com. The
information contained on, or that can be accessed through, our website is not part of this
prospectus, and you should not rely on any such information in making a decision about whether to
purchase shares of our common stock.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">



<DIV align="left">
<A name="C15401102"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Certain statements discussed in this prospectus constitute forward-looking statements, which
include financial projections, statements of plans and objectives for future operations, statements
of future economic performance, and statements of assumptions relating thereto. Forward-looking
statements are often identified by future or conditional words such as &#147;will&#148;, &#147;plans&#148;, &#147;expects&#148;,
&#147;intends&#148;, &#147;believes&#148;, &#147;seeks&#148;, &#147;estimates&#148;, or &#147;anticipates&#148;, or by variations of such words or by
similar expressions. There can be no assurances that forward-looking statements will be achieved.
By their very nature, forward-looking statements involve known and unknown risks, uncertainties,
and other important factors that could cause our actual results or conditions to differ materially
from those expressed or implied by such forward-looking statements. Important risks,
uncertainties, and other factors that could cause our actual results or conditions to differ
materially from our forward-looking statements include, among others:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">uncertainties regarding the impact of general economic conditions, particularly
in information technology spending, on our business;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks due to aggressive competition in all of our markets, including with
respect to maintaining margins and sufficient levels of investment in our business;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with keeping pace with technological changes and evolving
industry standards in our product offerings and with successfully introducing new,
quality products which meet customer needs and achieve market acceptance;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks created by continued consolidation of competitors or introduction of large
competitors in our markets with greater resources than we have;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that customers or partners delay or cancel orders or are unable to honor
contractual commitments due to liquidity issues, challenges in their business, or
otherwise;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks relating to our implementation and maintenance of adequate systems and
internal controls for our current and future operations and reporting needs and
related risks of financial statement omissions, misstatements, restatements, or
filing delays;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with being a consolidated, controlled subsidiary of Comverse
Technology, Inc., or Comverse, and formerly part of Comverse&#146;s consolidated tax
group, including risks of any future impact on us resulting from Comverse&#146;s
extended filing delay or any other future issues;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with Comverse controlling our board of directors and the
outcome of all matters submitted for stockholder action, including the approval of
significant corporate transactions, such as certain equity issuances or mergers and
acquisitions, as well as speculation or announcements regarding Comverse&#146;s
strategic plans;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that products may contain undetected defects which could expose us to
substantial liability;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with allocating limited financial and human resources to
opportunities that may not come to fruition or produce satisfactory returns;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with significant foreign and international operations,
including exposure to fluctuations in exchange rates;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with complex and changing local and foreign regulatory
environments;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with our ability to recruit and retain qualified personnel in
geographies in which we operate;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with mergers and acquisitions and with related system
integrations and asset impairments;</DIV></TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">challenges in accurately forecasting revenue and expenses and maintaining
profitability;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks relating to our ability to improve our infrastructure to support growth;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that our intellectual property rights may not be adequate to protect our
business or assets or that others may make claims on our intellectual property or
claim infringement on their intellectual property rights;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with a significant amount of our business coming from domestic
and foreign government customers, including the ability to maintain security
clearances for certain projects;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that we improperly handle sensitive or confidential information or
perception of such mishandling;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with our dependence on a limited number of suppliers or
original equipment manufacturers for certain components of our products;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that we are unable to maintain and enhance relationships with key
resellers, partners, and systems integrators;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that contract terms may expose us to unlimited liability or other
unfavorable positions and risks that we may experience losses that are not covered
by insurance;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that we will experience liquidity or working capital issues and related
risks that financing sources will be unavailable to us on reasonable terms or at
all;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with significant leverage resulting from our current debt
position;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that we will be unable to comply with the leverage ratio covenant or
financial statement delivery covenant under our credit facility;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that our credit rating could be downgraded or placed on a credit watch;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks relating to timely implementation of new accounting pronouncements or new
interpretations of existing accounting pronouncements and related risks of future
restatements or filing delays;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks associated with future regulatory actions or private litigations relating
to our extended filing delay and related circumstances; and</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">risks that use of our tax benefits may be restricted or eliminated in the
future.</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">You should carefully review the section entitled &#147;Risk Factors&#148; beginning on page 4 of this
prospectus and the other risk factors set forth in our periodic and other filings with the SEC,
including those set forth in our Annual Report on Form 10-K for the year ended January&nbsp;31, 2011,
for a discussion of these and other risks that relate to our business and an investment in shares
of our common stock. You are cautioned not to place undue reliance on forward-looking statements,
which reflect our management&#146;s view only as of the date of such statements. We make no commitment
to revise or update any forward-looking statements in order to reflect events or circumstances
after the date any such statement is made, except as otherwise required under the federal
securities laws. If we were in any particular instance to update or correct a forward-looking
statement, investors and others should not conclude that we would make additional updates or
corrections thereafter except as otherwise required under the federal securities laws.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>RISK FACTORS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><I>Investing in shares of our common stock involves a high degree of risk. You should carefully
review the risks described below and the other risk factors set forth in our periodic and other
filings with the SEC, including those set forth in our Annual Report on </I><I>Form 10-K</I><I> for the year
ended January&nbsp;31, 2011, together with the other information contained in and incorporated by
reference into this prospectus, before making an investment decision. Our business, results of
operations and financial condition may be materially and adversely affected due to any of these
risks. The trading price of our shares could decline due to any of these risks, and you could lose
all or part of your investment. Some risk factors in this section are &#147;forward-looking
statements.&#148; See &#147;Cautionary Note on Forward-Looking Statements.&#148;</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Risks Related To Our Common Stock</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 1%"><B><I>We do not plan to pay dividends on our common stock for the foreseeable future.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We intend to retain our earnings to support the development and expansion of our business, to
repay debt and for other corporate purposes and, as a result, we do not plan to pay cash dividends
on our common stock in the foreseeable future. Our payment of any future dividends will be at the
discretion of our board of directors after taking into account various factors, including our
financial condition, operating results, cash needs, growth plans and the terms of any credit
facility or other restrictive debt agreements that we may be a party to at the time or senior
securities we may have issued. Our credit facility limits us from paying cash dividends or other
payments or distributions with respect to our capital stock. In addition, the terms of any future
facility or other restrictive debt credit agreement may contain similar restrictions on our ability
to pay any dividends or make any distributions or payments with respect to our capital stock. In
addition, holders of our preferred stock are entitled to cumulative dividends before any dividends
may be declared or set aside on our common stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Furthermore, our ability to pay dividends to our stockholders is subject to the restrictions
set forth under Delaware law. We cannot assure you that we will meet the criteria specified under
Delaware law in the future, in which case we may not be able to pay dividends on our common stock
even if we were to choose to do so.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 1%"><B><I>The price of our common stock fluctuates significantly, and this may make it difficult for you
to resell the common stock when you want to or at prices you find attractive.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">There has been significant volatility in the market price and trading volume of equity
securities, including our common stock, some of which is unrelated to the financial performance of
the companies issuing the securities. The price for the shares of common stock being sold under
this prospectus may not be indicative of prices that will prevail in the open market following your
purchase of such shares. You may not be able to resell your shares at or above the price you paid
due to fluctuations in the market price of our common stock caused by changes in our operating
performance or prospects and other factors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Some specific factors that may have a significant effect on our common stock market price
include:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">actual or anticipated quarterly fluctuations in our operating and financial
results;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">the success of competitive service offerings or technologies;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">the timing of announcements in the public market regarding new products, product
enhancements or technological advances by our competitors or us;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">any announcements by us or our competitors of acquisitions, major transactions,
or management changes;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">speculation in the press and the analyst community, including with respect to
Comverse&#146;s strategic plans;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">announcements relating to Comverse&#146;s strategic plans;</DIV></TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">changes in recommendations or earnings estimates by financial analysts;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">changes in investors&#146; or analysts&#146; valuation measures for our stock;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">our credit ratings;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">market trends unrelated to our performance;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">stock sales by Comverse or our directors, officers, or other significant
holders;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">developments related to investigations, proceedings, or litigation that involve
us;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">regulatory developments; and</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">developments related to the industries in which we compete.</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">A significant drop in our stock price could also expose us to the risk of securities class
actions lawsuits, which could result in substantial costs and divert management&#146;s attention and
resources, which could adversely affect our business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Because our common stock has been re-listed on the NASDAQ Global Market only since July&nbsp;6,
2010, we cannot predict the extent to which investor interest in our company will lead to the
development of an active trading market on the NASDAQ Global Market or otherwise or how liquid that
market might become. Unless there is an active trading market for our common stock, you may have
difficulty selling any shares of our common stock that you purchase. Consequently, you may not be
able to sell our common stock at prices equal to or greater than the price you paid.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 1%"><B><I>Sales or potential sales of our common stock by us or our significant stockholders may cause the
market price of our common stock to decline.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We are not restricted from issuing additional shares of common stock, including shares
issuable pursuant to securities that are convertible into or exchangeable for, or that represent
the right to receive, common stock. As of March&nbsp;23, 2011, we had 37.1&nbsp;million shares of common
stock outstanding. In addition, as of that date, approximately 4.0&nbsp;million shares of our common
stock (including the 35,815 shares included in this prospectus, which were acquired by the selling
stockholders on April&nbsp;10, 2011) were issuable pursuant to outstanding stock options and awards
which had not yet vested or which had been previously acquired upon vesting but had not yet been
delivered. Additional shares of common stock are also available to be granted under our existing
equity plans or may be granted under future equity plans. In addition, under two registration
rights agreements that we entered into with Comverse, Comverse has registration rights with respect
to its common stock and preferred stock holdings in Verint. As of January&nbsp;31, 2011, the preferred
stock was convertible into approximately 10.4&nbsp;million shares of our common stock. Stock sales by
Comverse or our directors, officers, or other significant holders may affect our stock price.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 1%"><B><I>Anti-takeover provisions in Delaware corporate law may make it difficult for our stockholders to
replace or remove our current board of directors and could deter or delay third-parties from
acquiring us, which may adversely affect the marketability and market price of our common stock.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We are subject to the anti-takeover provisions of Section&nbsp;203 of the Delaware General
Corporation Law. Under these provisions, if anyone becomes an &#147;interested stockholder&#148;, we may not
enter into a &#147;business combination&#148; with that person for three years without special approval,
which could discourage a third party from making a takeover offer and could delay or prevent a
change of control. For purposes of Section&nbsp;203, &#147;interested stockholder&#148; means, generally, someone
owning more than 15% or more of our outstanding voting stock or an affiliate of ours that owned 15%
or more of our outstanding voting stock during the past three years, subject to certain exceptions
as described in Section&nbsp;203.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Under any change of control, as defined in our credit agreement, the lenders under our credit
facility would have the right to require us to repay all of our outstanding obligations under the
facility. Upon the occurrence of a &#147;Fundamental Change&#148;, as defined by the Certificate of
Designation setting forth the terms of the preferred stock, and which includes a change of control,
the holders of our preferred stock have the right to require us to repurchase their shares of
preferred stock at the then current liquidation preference (subject to certain exceptions set forth
in the Certificate of Designation).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 1%"><B><I>Holders of our preferred stock have liquidation and other rights that are senior to the rights
of the holders of our common stock.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Our board of directors has the authority to designate and issue preferred stock that may have
dividend, liquidation and other rights that are senior to those of our common stock. As of January
31, 2011, 293,000 shares of our preferred stock have been issued and are outstanding. As of
January&nbsp;31, 2011, the preferred stock was convertible into approximately 10.4&nbsp;million shares of our
common stock. Holders of our preferred stock are entitled to cumulative dividends before any
dividends may be declared or set aside on our common stock. Upon our voluntary or involuntary
liquidation, dissolution or winding up, before any payment is made to holders of our common stock,
holders of our preferred stock are entitled to receive an initial liquidation preference of $1,000
per share, plus any accrued and unpaid dividends, which liquidation preference was approximately
$338.7&nbsp;million in the aggregate as of January&nbsp;31, 2011. This will reduce the remaining amount of
our assets, if any, available to distribute to holders of our common stock.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>USE OF PROCEEDS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The proceeds from the sale of the common stock
covered by this prospectus are solely for the accounts of the selling stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We will bear all costs, expenses and fees in connection with the registration of the shares.
Brokerage commissions and similar selling expenses, if any, attributable to the offer or sale of
the shares will be borne by the selling stockholders.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401105"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SELLING STOCKHOLDERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">This prospectus relates to shares of our common stock previously issued pursuant to the Plans
to certain of our employees that are being registered for resale. All of the shares of common
stock that may be resold pursuant to this prospectus were previously acquired by the selling
stockholders upon the satisfaction of applicable vesting conditions relating to certain equity
awards (i.e., stockholder approval of a new equity compensation plan or our having additional share
capacity under one of our existing stockholder-approved equity compensation plans and/or the
passage of time).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The selling stockholders may resell any or all of such shares of common stock at any time they
choose while this prospectus is effective. The inclusion in this prospectus of the employees named
below who have acquired shares of our common stock under the Plans shall not be deemed to be an
admission that any such individual is an &#147;affiliate&#148; of ours. There is no assurance that any of
the selling stockholders will sell any or all of the shares of common stock covered by this
prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The following is a list of our employees, regardless of number of shares held, who previously
acquired shares of our common stock in connection with a vesting event that took place on April&nbsp;10,
2011, pursuant to awards previously granted under the Plans, whose shares are being registered for
resale pursuant to this prospectus. These employees may sell up to an aggregate of 35,815 shares
of common stock, representing less than 1% of our issued and outstanding shares of common stock.
This percentage of ownership is based on 37,142,644 shares of our common stock issued and
outstanding as of March&nbsp;23, 2011 plus an additional 289,930 shares of our common stock that were
acquired by our officers, directors and employees pursuant to vesting events occurring after that
date, including the 35,815 shares of our common stock that may be offered pursuant to this
prospectus that were acquired by the selling stockholders on April&nbsp;10, 2011, for a total of
37,432,574 shares.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Eli Arman
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gabriel Horowitz
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Carl David Robson</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Sunil Aryan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary W. Humphrey
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bryan Melvyn Rose</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Kar Ashutosh
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ron Jenik
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elizabeth Russell</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Zwicka Ben Zion
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jay Jennings
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">William Ryan</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amy Blank
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jeff D. Jue
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">William D. Schneider</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Katherine Bost
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Steve Kaden
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Omer Shavit</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jean Boudreau
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kevin Kurimsky
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jim Sherring</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Richard Branchaud
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Adam Wan Fung Kwok
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ziv Simhon</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Josef Bronstein
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amanda Lewis
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">David Singer</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Brian Carman
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michel J. Manche
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kevin J. Steel</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Kenneth Carney
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mary Christine McAleer
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">David Stone</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">William Stuart Caton III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John McCourt
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ram Swery</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Donna Colby
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James Moretti
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Guy Tamir</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Sue Cordaro
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Christopher Nelson
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Matthew Paul Tengwall</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Patrick Dagenais
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kasey Newman
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary S. Trudo</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Andrew Davies
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Robert Nyberg
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Daniel Vitlis</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">William L. Eckard III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Christopher Orr
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Daniel Weiss</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Charles Ehlers
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul Patton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Timothy Wilkie</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Karen Flynn
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jose Fortuna Penaredondo
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jon Wilson</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Michael Gagnon
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Colin Maurice Pope
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alexander Zur</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Siddartha Gandhi
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sean Quigley</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Andrew Robert Hawkes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Matthew Robson</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401106"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The selling stockholders have not advised us of any specific plan for the sale or distribution
of the shares of common stock covered by this prospectus. If and when they occur, such sales may
be made in any of the following manners:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">on the NASDAQ Global Market (or through the facilities of any national
securities exchange or U.S. inter-dealer quotation system of a registered national
securities association on which shares of our common stock are then listed,
admitted to unlisted trading privileges or included for quotation);</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">in public or privately negotiated transactions;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">in transactions involving principals or brokers;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">in a combination of such methods of sale; or</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">any other lawful methods.</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Although sales of the shares of common stock covered by this prospectus are, in general,
expected to be made at market prices prevailing at the time of sale, the shares may also be sold at
prices related to such prevailing market prices or at negotiated prices, which may differ
considerably.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">When offering the shares of common stock covered by this prospectus, each of the selling
stockholders and any broker-dealers who sell the shares for the selling stockholders may be
&#147;underwriters&#148; within the meaning of the Securities Act, and any profits realized by such selling
stockholders and the compensation of such broker-dealers may be underwriting discounts and
commissions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Sales through brokers may be made by any method of trading authorized by any stock exchange or
market on which our common stock may be listed, including block trading in negotiated transactions.
Without limiting the foregoing, such brokers may act as dealers by purchasing any or all of the
shares of common stock covered by this prospectus, either as agents for others or as principals for
their own accounts, and reselling such shares pursuant to this prospectus. The selling
stockholders may effect such transactions directly, or indirectly through underwriters,
broker-dealers or agents acting on their behalf. In connection with such sales, such
broker-dealers or agents may receive compensation in the form of commissions, concessions,
allowances or discounts, any or all of which might be in excess of customary amounts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Each of the selling stockholders is acting independently of us in making decisions with
respect to the timing, manner and size of each sale of shares. We have not been advised of any
definitive selling arrangement at the date of this prospectus between any selling stockholder and
any broker-dealer or agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">To the extent required, the names of any agents, broker-dealers or underwriters and applicable
commissions, concessions, allowances or discounts, and any other required information with respect
to any particular offer of the shares by the selling stockholders, will be set forth in a
prospectus supplement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The expenses of preparing and filing this prospectus and the related registration statement
with the SEC will be paid entirely by us. The selling stockholders have been advised that they are
subject to the applicable provisions of the Exchange Act, including without limitation Rule&nbsp;10b-5
thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Neither we nor the selling stockholders can currently estimate the amount of commissions or
discounts, if any, that will be paid by the selling stockholders on account of their sales of the
shares from time to time.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401107"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The validity of the issuance of the shares of common stock offered in this prospectus will be
passed upon for us by Jones Day, New York, New York.
</DIV>
<DIV align="left">
<A name="C15401108"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The consolidated financial statements, incorporated in this prospectus by reference from
Verint Systems Inc.&#146;s Annual Report on Form 10-K for the year ended January&nbsp;31, 2011, and the
effectiveness of Verint Systems Inc.&#146;s internal control over financial reporting as of January&nbsp;31,
2011 have been audited by Deloitte &#038; Touche LLP, an independent registered public accounting firm,
as stated in their reports, which are incorporated herein by reference. Such consolidated financial
statements have been so incorporated in reliance upon the reports of such firm given upon their
authority as experts in accounting and auditing.
</DIV>
<DIV align="left">
<A name="C15401109"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION INCORPORATED BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The SEC allows us to incorporate by reference certain of our publicly filed documents into
this prospectus, which means that we can disclose important business and financial information to
you that is not included in or delivered with this prospectus by referring you to publicly filed
documents that contain the omitted information. The information incorporated by reference is
considered to be part of this prospectus, and any later information that we file with the SEC will
automatically update and supersede this information. You will be deemed to have notice of all
information incorporated by reference into this prospectus as if that information were included in
this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The following documents that we have filed with the SEC are incorporated herein by reference:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">our Annual Report on Form 10-K for the year ended January&nbsp;31, 2011, filed with
the SEC on April&nbsp;6, 2011;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">our Current Reports on Form 8-K, filed with the SEC on March&nbsp;3, 2011 and March
30, 2011; and</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">the description of our common stock, par value $0.001 per share, contained in
our Registration Statement on Form 8-A, filed with the SEC on July&nbsp;2, 2010.</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Except as otherwise indicated, all documents we file with the SEC pursuant to Sections&nbsp;13(a),
13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the
filing of a post-effective amendment that indicates that all securities offered have been sold or
that deregisters all securities then remaining unsold will be deemed to be incorporated by
reference into this prospectus and to be part hereof from the date of filing of such documents.
Any statement contained in any document incorporated or deemed to be incorporated by reference
herein will be deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained herein or in any other subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded will not be deemed, except as modified or superseded, to
constitute a part of this prospectus. This prospectus is part of a Registration Statement on Form
S-8 that we filed with the SEC and does not contain all of the information set forth in that
Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We will provide, free of charge, to any person to whom a copy of this prospectus is delivered,
upon written or oral request, a copy of any or all of the documents incorporated by reference into
this prospectus, other than exhibits to those documents unless specifically incorporated by
reference. To request a copy of those documents, you should contact us as set forth below under
&#147;Where You Can Find Additional Information.&#148;
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401110"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We file annual, quarterly and current reports, proxy statements, and other information with
the SEC. The SEC allows us to incorporate by reference the information we file with it, which
means that we can disclose important business and financial information to you that is not included
in or delivered with this prospectus by referring you to publicly filed documents that contain the omitted information. We provide a
list of all documents we incorporate by reference into this prospectus under &#147;Information
Incorporated by Reference&#148; above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Through our website at www.verint.com, we make available the information that we incorporate
by reference into this prospectus, as well as other reports, proxy statements, and other
information that we file with the SEC. You may also read and copy those materials at the SEC&#146;s
Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at (800)
SEC-0330 for further information on the operation of the Public Reference Room. In addition, we
are required to file electronic versions of those materials with the SEC through the SEC&#146;s EDGAR
system. The SEC maintains a website at www.sec.gov that contains reports, proxy statements, and
other information that registrants, such as we, file electronically with the SEC. Our website
address set forth above is not intended to be an active link, and information on our website is not
incorporated in, and should not be construed to be a part of, this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Each person to whom a prospectus is delivered may also request a copy of those materials, free
of charge, by contacting us at:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">Verint Systems Inc.<BR>
330 South Service Road<BR>
Melville, New York 11747<BR>
(631)&nbsp;962-9600<BR>
Attn: Corporate Secretary
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">




<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PART II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>


<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;3.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Incorporation of Documents by Reference.</B></DIV></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The following documents filed by the Company with the Commission are incorporated herein by
reference:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">the Company&#146;s Annual Report on Form 10-K for the year ended January&nbsp;31, 2011, filed
with the Commission on April&nbsp;6, 2011;</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">the Company&#146;s Current Reports on Form 8-K, filed with the Commission on March&nbsp;3,
2011 and March&nbsp;30, 2011; and</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><DIV style="text-align: justify">the description of the Company&#146;s common stock, par value $0.001 per share, contained
in the Company&#146;s Registration Statement on Form 8-A, filed with the Commission on July
2, 2010.</DIV></TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">All documents filed by the Company with the Commission pursuant to Sections&nbsp;13(a), 13(c), 14
and 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), subsequent to
the date of this Registration Statement and prior to the filing of a post-effective amendment that
indicates that all securities offered have been sold or which deregisters all securities then
remaining unsold will be deemed to be incorporated by reference in this Registration Statement and
to be part hereof from the date of filing of such documents. Any statement contained in any
document incorporated or deemed to be incorporated by reference herein will be deemed to be
modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so
modified or superseded will not be deemed, except as modified or superseded, to constitute a part
of this Registration Statement.
</DIV>

<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;4.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Description of Securities.</B></DIV></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Not applicable.
</DIV>

<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;5.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Interests of Named Experts and Counsel.</B></DIV></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Not applicable.
</DIV>

<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;6.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Indemnification of Directors and Officers.</B></DIV></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Section&nbsp;102 of the General Corporation Law of the State of Delaware, or the DGCL, permits a
corporation to eliminate the personal liability of directors of a corporation to the corporation or
its stockholders for monetary damages for a breach of fiduciary duty as a director, except where
the director breached his duty of loyalty, failed to act in good faith, engaged in intentional
misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock
repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our
amended and restated certificate of incorporation provides that none of our directors shall be
personally liable to Verint or our stockholders for monetary damages for any breach of fiduciary
duty as a director, except (i)&nbsp;for any breach of the director&#146;s duty of loyalty to Verint or its
stockholders, or (ii)&nbsp;for acts or omissions which are not taken or omitted to be taken in good
faith or which involve intentional misconduct or knowing violation of the law, or (iii)&nbsp;for any
matter in respect of which such director shall be liable under Section&nbsp;174 of Title 8 of the DGCL
or any amendment or successor provision thereto, or (iv)&nbsp;for any transaction from which the
director shall have derived an improper personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Section&nbsp;145 of the DGCL provides that a corporation has the power to indemnify a director,
officer, employee, or agent of the corporation, or a person serving at the request of the
corporation for another corporation, partnership, joint venture, trust or other enterprise in
related capacities, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by the person in connection with an action, suit or
proceeding to which he was or is a party or is threatened to be made a party to any threatened,
ending or completed action, suit or proceeding by reason of such position, if such person acted in
good faith and in a
manner he reasonably believed to be in or not opposed to the best interests of the
corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his
conduct was unlawful, except that, in the case of actions brought by or in the right of the
corporation, no indemnification shall be made with respect to any claim, issue or matter as to
which such person shall have been adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or other adjudicating court determines that, despite the
adjudication of liability but in view of all of the circumstances of the case, such person is
fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such
other court shall deem proper.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Our certificate of incorporation provides that every person who is or was our director,
officer, employee or agent or is or was a director, officer, trustee, employee or agent of any
other enterprise, serving as such at our request, shall be indemnified to the fullest extent
permitted by law for all expenses and liabilities in connection with any proceeding involving such
person in this capacity. We entered into an indemnification agreement with each of our directors
and officers under which we agreed to provide indemnification and expense reimbursement as outlined
above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Each of our directors who is also a director and/or officer of Comverse has an indemnification
agreement with Comverse. Under this agreement, Comverse has agreed to indemnify such person
against losses and expenses, to the extent permitted by law, incurred by such person in connection
with his service as director and/or officer of Comverse or any of its subsidiaries.
</DIV>

<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;7.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Exemption from Registration Claimed.</B></DIV></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">As previously disclosed, as a result of the Company&#146;s inability to file required reports with
the Commission during the Company&#146;s extended filing delay period, the Company previously ceased
using its existing registration statements on Form S-8 to make equity grants to employees. On May
24, 2007, the Company received a no-action letter from the Commission upon which the Company relied
to make broad-based equity grants to employees under a no-sale theory. The Company has also made
equity grants to certain employees in transactions that did not involve public offerings and that
were exempt from registration under the Securities Act of 1933 under Section&nbsp;4(2) of and/or
Regulation&nbsp;D and/or Regulation&nbsp;S under the Securities Act of 1933. All of the shares of common
stock that may be offered pursuant to this registration statement were acquired by the selling
stockholders upon the grant of restricted stock pursuant to an applicable exemption from the
registration requirements of the Securities Act of 1933 or the vesting of equity awards issued
pursuant to the no-sale theory or an applicable exemption from registration.
</DIV>

<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;8.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Exhibits.</B></DIV></TD>
</TR>
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Filed Herewith /</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Incorporated by Reference</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD  nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>from</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission File No.
333-82300) effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Designation, Preferences and Rights of the Series&nbsp;A
Convertible Perpetual Preferred Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on May&nbsp;30, 2007</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated By-laws of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on January&nbsp;7, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Common Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission File No.
333-82300) effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Series&nbsp;A Convertible Perpetual Preferred Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as amended
and restated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on January&nbsp;10, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.5</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Witness Systems Amended and Restated Stock Incentive Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc. Form&nbsp;10-Q
filed on August&nbsp;9, 2005</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
</TR>



<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Filed Herewith /</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Incorporated by Reference</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>from</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.6</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Witness Systems Amended and Restated Stock Incentive
Plan (dated May&nbsp;29, 2001)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc. Form&nbsp;10-K
filed on March&nbsp;17, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.7</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;2 to Witness Systems Amended and Restated Stock Incentive
Plan (dated January&nbsp;15, 2004)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc. Form&nbsp;10-K
filed on March&nbsp;15, 2004</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.8</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;3 to Witness Systems Amended and Restated Stock Incentive
Plan (dated December&nbsp;6, 2007)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.9</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;4 to Witness Systems Amended and Restated Stock Incentive
Plan (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Jones Day
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Deloitte &#038; Touche LLP
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Jones Day (included in Exhibit&nbsp;5.1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="7%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;9.</B></TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="text-align: justify"><B>Undertakings.</B></DIV></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(a)&nbsp;The undersigned Registrant hereby undertakes:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 8%">(i)&nbsp;to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 8%">(ii)&nbsp;to reflect in the prospectus any facts or events arising after the effective date
of this registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this registration statement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 8%">(iii)&nbsp;to include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such
information in this registration statement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><I>provided, however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the registration
statement is on Form S-8, and the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Commission by the
Registrant pursuant to Section&nbsp;13 or Section 15(d) of the Exchange Act that are incorporated by
reference in this registration statement.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(2)&nbsp;That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time will be deemed to be
the initial <I>bona fide </I>offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(3)&nbsp;To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(b)&nbsp;The undersigned Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act, each filing of the Registrant&#146;s annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this registration statement will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that
time will be deemed to be the initial <I>bona fide </I>offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with
the securities being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">
<DIV align="left">
<A name="C15401111"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the city of Melville, State of New York, on this 11th day of April,
2011.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">VERINT SYSTEMS INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Dan Bodner
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Dan Bodner&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
been signed by the following persons in the capacities and on the dates indicated.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="60%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Dan Bodner
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Dan Bodner, Chief Executive Officer and President;<br>Director of Verint Systems Inc.<br>
(Principal Executive Officer)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Douglas E. Robinson
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Douglas E. Robinson, Chief Financial Officer of Verint Systems Inc.<br>
(Principal Financial Officer and Principal Accounting Officer)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Paul D. Baker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Paul D. Baker, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ John Bunyan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
John Bunyan, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Charles J. Burdick
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Charles J. Burdick, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Victor A. DeMarines
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Victor A. DeMarines, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Larry Myers
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Larry Myers, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Howard Safir
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Howard Safir, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Shefali Shah
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Shefali Shah, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;11, 2011&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#C15401tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.50in">



<DIV align="left">
<A name="C15401112"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Filed Herewith /</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Incorporated by Reference</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>from</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of Verint
Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission
File No.&nbsp;333-82300)
effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Designation, Preferences and Rights of the Series&nbsp;A
Convertible Perpetual Preferred Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on May
30, 2007</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated By-laws of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on
January&nbsp;7, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Common Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission
File No.&nbsp;333-82300)
effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Series&nbsp;A Convertible Perpetual Preferred Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March
17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended and restated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on
January&nbsp;10, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December&nbsp;23,
2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March
17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.5</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Witness Systems Amended and Restated Stock Incentive Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-Q filed on
August&nbsp;9, 2005</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.6</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Witness Systems Amended and Restated Stock
Incentive Plan (dated May&nbsp;29, 2001)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-K filed on March
17, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.7</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;2 to Witness Systems Amended and Restated Stock
Incentive Plan (dated January&nbsp;15, 2004)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-K filed on March
15, 2004</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.8</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;3 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December&nbsp;6, 2007)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March
17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.9</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;4 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March
17, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Jones Day
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Deloitte &#038; Touche LLP
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Jones Day (included in Exhibit&nbsp;5.1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c15401sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 149063}]
{"company-data": {"conformed-name": "VERINT SYSTEMS INC", "cik": "0001166388", "assigned-sic": "7373", "irs-number": "113200514", "state-of-incorporation": "DE", "fiscal-year-end": "0131"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-173421", "film-number": "11751583"}, "business-address": {"street1": "330 SOUTH SERVICE ROAD", "city": "MELVILLE", "state": "NY", "zip": "11747", "phone": "6319629600"}, "mail-address": {"street1": "330 SOUTH SERVICE ROAD", "city": "MELVILLE", "state": "NY", "zip": "11747"}}
sv8
Table of Contents
As filed with the Securities and Exchange Commission on April 11, 2011
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
VERINT SYSTEMS INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
11-3200514
(I.R.S. Employer Identification No.)
330 South Service Road, Melville, New York
11747
(Address of Principal Executive Offices)
(Zip Code)
VERINT SYSTEMS INC. 2004 STOCK INCENTIVE COMPENSATION PLAN
WITNESS SYSTEMS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN
(Full title of the plan)
Peter Fante, Esq.
Chief Legal Officer
Verint Systems Inc.
330 South Service Road
Melville, New York 11747
(Name and address of agent for service)
(631) 962-9600
(Telephone number, including area code, of agent for service)
With copies to:
Randi C. Lesnick, Esq.
Jones Day
222 East 41
st
Street
New York, New York 10017
(212) 326-3939
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated
filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
(Check one):
Large accelerated filer
o
Accelerated
filer
þ
Non-accelerated filer
o
Smaller reporting company
o
(Do not check if a smaller reporting company)
CALCULATION OF REGISTRATION FEE
Proposed Maximum
Proposed Maximum
Title of Securities to be
Amount to be
Offering Price Per
Aggregate Offering
Amount of
Registered
Registered
(1)(2)
Share
(3)
Price
(3)
Registration Fee
Common Stock, $0.001 par
value per share
35,815
$
36.545
$
1,308,859.18
$151.96
(1)
Pursuant to Rule 416 under the Securities Act of 1933 (the "Securities Act"), this
Registration Statement shall include any additional shares of common stock, par value $0.001
per share (the "Common Stock"), that may become issuable as a result of stock splits, stock
dividends or similar transactions.
(2)
Represents 21,760 shares of Common Stock previously issued pursuant to the Verint Systems
Inc. 2004 Stock Incentive Compensation Plan, as amended, to be registered for resale and
14,055 shares of Common Stock previously issued pursuant to the Witness Systems, Inc. Amended
and Restated Stock Incentive Plan, as amended, to be registered for resale. The Common Stock
has been previously issued to employees.
(3)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant
to Rule 457(c) under the Securities Act, based on the average of the high and low prices of
our Common Stock as reported by the NASDAQ Global Market on April 5, 2011.
Table of Contents
EXPLANATORY NOTE
This Registration Statement contains two parts. The first part contains a resale prospectus
prepared in accordance with the requirements of General Instruction C to Form S-8 that covers
resales of "restricted securities" and "control securities" (in each case, as defined in General
Instruction C to Form S-8). This resale prospectus relates to shares of common stock, $0.001 par
value per share, of Verint Systems Inc. (the "Company") previously issued to certain employees of
the Company pursuant to the Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as amended,
and the Witness Systems, Inc. Amended and Restated Stock Incentive Plan, as amended. The second
part of this Registration Statement contains Information Required in the Registration Statement
pursuant to Part II of Form S-8.
Table of Contents
REOFFER PROSPECTUS
VERINT SYSTEMS INC.
35,815 SHARES OF COMMON STOCK
This prospectus relates to the resale, from time to time, of up to 35,815 shares of our common
stock, $0.001 par value per share, by the selling stockholders listed in this prospectus. The
selling stockholders acquired such shares pursuant to grants made under (1) the Verint Systems Inc.
2004 Stock Incentive Compensation Plan, as amended, and (2) the Witness Systems, Inc. Amended and
Restated Stock Incentive Plan, as amended. The Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended, and the Witness Systems, Inc. Amended and Restated Stock Incentive
Plan, as amended, are collectively referred to in this prospectus as the "Plans."
We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The shares may be offered, from time to time, by
any or all of the selling stockholders through ordinary brokerage transactions, in negotiated
transactions or in other transactions, at such prices as he, she or they may determine, which may
relate to market prices prevailing at the time of sale or be a negotiated price. See "Plan of
Distribution." We will bear all costs, expenses and fees in connection with the registration of
the shares. Brokerage commissions and similar selling expenses, if any, attributable to the offer
or sale of the shares will be borne by the selling stockholders.
Each selling stockholder and any broker executing selling orders on behalf of a selling
stockholder may be deemed to be an "underwriter" as defined in the Securities Act of 1933, as
amended, or the Securities Act. If any broker-dealers are used to effect sales, any commissions
paid to broker-dealers and, if broker-dealers purchase any of the shares of common stock covered by
this prospectus as principals, any profits received by such broker-dealers on the resales of shares
may be deemed to be underwriting discounts or commissions under the Securities Act. In addition,
any profits realized by the selling stockholders may be deemed to be underwriting commissions.
Shares of our common stock are listed on the NASDAQ Global Market under the symbol "VRNT." On
April 8, 2011, the last reported sale price of our common stock was $36.70 per share.
Investing in shares of our common stock involves a high degree of risk. See "Risk Factors" on
page 4 of this prospectus and the other risk factors set forth in our periodic and other filings
with the Securities and Exchange Commission, or the SEC, including those set forth in our Annual
Report on Form 10-K for the year ended January 31, 2011, for a discussion of certain factors that
should carefully be considered by prospective purchasers.
Neither the SEC nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.
This prospectus is dated April 11, 2011.
TABLE OF CONTENTS
Prospectus Summary
1
Cautionary Note on Forward-Looking Statements
2
Risk Factors
4
Use of Proceeds
7
Selling Stockholders
8
Plan of Distribution
9
Legal Matters
10
Experts
10
Information Incorporated by Reference
10
Where You Can Find Additional Information
11
EX-5.1
EX-23.1
You should rely only on the information contained in or incorporated by reference into this
prospectus. We have not authorized any other person to provide you with additional information or
information different from that contained in or incorporated by reference into this prospectus.
The selling stockholders may, from time to time, offer to sell shares of our common stock only in
jurisdictions where the offer or sale is permitted. You should not assume that the information
contained in this prospectus is accurate as of any date other than the date on the front cover of
this prospectus or that the information contained in any document incorporated by reference into
this prospectus is accurate as of any date other than the date of the document incorporated by
reference.
i
Table of Contents
PROSPECTUS SUMMARY
This summary highlights information contained elsewhere in or incorporated by reference into
this prospectus. This summary is not complete and does not contain all of the information that may
be important to you and that you should consider before investing in shares of our common stock.
You should carefully read the entire prospectus, including the section titled "Risk Factors," and
the other information incorporated by reference into this prospectus before making an investment
decision.
References in this prospectus to the terms "Verint," "the Company," "we," "us" and "our," or
other similar terms, mean Verint Systems Inc., together with its consolidated subsidiaries, unless
the context indicates otherwise.
VERINT SYSTEMS INC.
Verint is a global leader in Actionable Intelligence
®
solutions and value-added services. Our
solutions enable organizations of all sizes to make timely and effective decisions to improve
enterprise performance and make the world a safer place. More than 10,000 organizations in over
150 countries—including over 85% of the Fortune 100—use Verint Actionable Intelligence solutions
to capture, distill, and analyze complex and underused information sources, such as voice, video,
and unstructured text.
In the enterprise market, our workforce optimization solutions help organizations enhance
customer service operations in contact centers, branches, and back-office environments to increase
customer satisfaction, reduce operating costs, identify revenue opportunities, and improve
profitability. In the security intelligence market, our video intelligence, public safety, and
communications intelligence solutions are vital to government and commercial organizations in their
efforts to protect people and property and neutralize terrorism and crime.
We have established leadership positions in both the enterprise workforce optimization and
security intelligence markets by leveraging our core competency in developing highly scalable,
enterprise-class applications with advanced, integrated analytics for both unstructured and
structured information. Our innovative solutions are developed by approximately 900 employees and
contractors in research and development, representing approximately one-third of our total
headcount, and are evidenced by more than 500 patents and patent applications worldwide. We offer
a range of customer services, from initial implementation to ongoing maintenance and support, to
maximize the value our customers receive from our Actionable Intelligence solutions and to allow us
to extend our customer relationships.
Our principal executive offices are located at 330 South Service Road, Melville, New York
11747. Our telephone number at that address is (631) 962-9600. Our website is www.verint.com. The
information contained on, or that can be accessed through, our website is not part of this
prospectus, and you should not rely on any such information in making a decision about whether to
purchase shares of our common stock.
1
Table of Contents
CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
Certain statements discussed in this prospectus constitute forward-looking statements, which
include financial projections, statements of plans and objectives for future operations, statements
of future economic performance, and statements of assumptions relating thereto. Forward-looking
statements are often identified by future or conditional words such as "will", "plans", "expects",
"intends", "believes", "seeks", "estimates", or "anticipates", or by variations of such words or by
similar expressions. There can be no assurances that forward-looking statements will be achieved.
By their very nature, forward-looking statements involve known and unknown risks, uncertainties,
and other important factors that could cause our actual results or conditions to differ materially
from those expressed or implied by such forward-looking statements. Important risks,
uncertainties, and other factors that could cause our actual results or conditions to differ
materially from our forward-looking statements include, among others:
•
uncertainties regarding the impact of general economic conditions, particularly
in information technology spending, on our business;
•
risks due to aggressive competition in all of our markets, including with
respect to maintaining margins and sufficient levels of investment in our business;
•
risks associated with keeping pace with technological changes and evolving
industry standards in our product offerings and with successfully introducing new,
quality products which meet customer needs and achieve market acceptance;
•
risks created by continued consolidation of competitors or introduction of large
competitors in our markets with greater resources than we have;
•
risks that customers or partners delay or cancel orders or are unable to honor
contractual commitments due to liquidity issues, challenges in their business, or
otherwise;
•
risks relating to our implementation and maintenance of adequate systems and
internal controls for our current and future operations and reporting needs and
related risks of financial statement omissions, misstatements, restatements, or
filing delays;
•
risks associated with being a consolidated, controlled subsidiary of Comverse
Technology, Inc., or Comverse, and formerly part of Comverse's consolidated tax
group, including risks of any future impact on us resulting from Comverse's
extended filing delay or any other future issues;
•
risks associated with Comverse controlling our board of directors and the
outcome of all matters submitted for stockholder action, including the approval of
significant corporate transactions, such as certain equity issuances or mergers and
acquisitions, as well as speculation or announcements regarding Comverse's
strategic plans;
•
risks that products may contain undetected defects which could expose us to
substantial liability;
•
risks associated with allocating limited financial and human resources to
opportunities that may not come to fruition or produce satisfactory returns;
•
risks associated with significant foreign and international operations,
including exposure to fluctuations in exchange rates;
•
risks associated with complex and changing local and foreign regulatory
environments;
•
risks associated with our ability to recruit and retain qualified personnel in
geographies in which we operate;
•
risks associated with mergers and acquisitions and with related system
integrations and asset impairments;
2
Table of Contents
•
challenges in accurately forecasting revenue and expenses and maintaining
profitability;
•
risks relating to our ability to improve our infrastructure to support growth;
•
risks that our intellectual property rights may not be adequate to protect our
business or assets or that others may make claims on our intellectual property or
claim infringement on their intellectual property rights;
•
risks associated with a significant amount of our business coming from domestic
and foreign government customers, including the ability to maintain security
clearances for certain projects;
•
risks that we improperly handle sensitive or confidential information or
perception of such mishandling;
•
risks associated with our dependence on a limited number of suppliers or
original equipment manufacturers for certain components of our products;
•
risks that we are unable to maintain and enhance relationships with key
resellers, partners, and systems integrators;
•
risks that contract terms may expose us to unlimited liability or other
unfavorable positions and risks that we may experience losses that are not covered
by insurance;
•
risks that we will experience liquidity or working capital issues and related
risks that financing sources will be unavailable to us on reasonable terms or at
all;
•
risks associated with significant leverage resulting from our current debt
position;
•
risks that we will be unable to comply with the leverage ratio covenant or
financial statement delivery covenant under our credit facility;
•
risks that our credit rating could be downgraded or placed on a credit watch;
•
risks relating to timely implementation of new accounting pronouncements or new
interpretations of existing accounting pronouncements and related risks of future
restatements or filing delays;
•
risks associated with future regulatory actions or private litigations relating
to our extended filing delay and related circumstances; and
•
risks that use of our tax benefits may be restricted or eliminated in the
future.
You should carefully review the section entitled "Risk Factors" beginning on page 4 of this
prospectus and the other risk factors set forth in our periodic and other filings with the SEC,
including those set forth in our Annual Report on Form 10-K for the year ended January 31, 2011,
for a discussion of these and other risks that relate to our business and an investment in shares
of our common stock. You are cautioned not to place undue reliance on forward-looking statements,
which reflect our management's view only as of the date of such statements. We make no commitment
to revise or update any forward-looking statements in order to reflect events or circumstances
after the date any such statement is made, except as otherwise required under the federal
securities laws. If we were in any particular instance to update or correct a forward-looking
statement, investors and others should not conclude that we would make additional updates or
corrections thereafter except as otherwise required under the federal securities laws.
3
Table of Contents
RISK FACTORS
Investing in shares of our common stock involves a high degree of risk. You should carefully
review the risks described below and the other risk factors set forth in our periodic and other
filings with the SEC, including those set forth in our Annual Report on
Form 10-K
for the year
ended January 31, 2011, together with the other information contained in and incorporated by
reference into this prospectus, before making an investment decision. Our business, results of
operations and financial condition may be materially and adversely affected due to any of these
risks. The trading price of our shares could decline due to any of these risks, and you could lose
all or part of your investment. Some risk factors in this section are "forward-looking
statements." See "Cautionary Note on Forward-Looking Statements."
Risks Related To Our Common Stock
We do not plan to pay dividends on our common stock for the foreseeable future.
We intend to retain our earnings to support the development and expansion of our business, to
repay debt and for other corporate purposes and, as a result, we do not plan to pay cash dividends
on our common stock in the foreseeable future. Our payment of any future dividends will be at the
discretion of our board of directors after taking into account various factors, including our
financial condition, operating results, cash needs, growth plans and the terms of any credit
facility or other restrictive debt agreements that we may be a party to at the time or senior
securities we may have issued. Our credit facility limits us from paying cash dividends or other
payments or distributions with respect to our capital stock. In addition, the terms of any future
facility or other restrictive debt credit agreement may contain similar restrictions on our ability
to pay any dividends or make any distributions or payments with respect to our capital stock. In
addition, holders of our preferred stock are entitled to cumulative dividends before any dividends
may be declared or set aside on our common stock.
Furthermore, our ability to pay dividends to our stockholders is subject to the restrictions
set forth under Delaware law. We cannot assure you that we will meet the criteria specified under
Delaware law in the future, in which case we may not be able to pay dividends on our common stock
even if we were to choose to do so.
The price of our common stock fluctuates significantly, and this may make it difficult for you
to resell the common stock when you want to or at prices you find attractive.
There has been significant volatility in the market price and trading volume of equity
securities, including our common stock, some of which is unrelated to the financial performance of
the companies issuing the securities. The price for the shares of common stock being sold under
this prospectus may not be indicative of prices that will prevail in the open market following your
purchase of such shares. You may not be able to resell your shares at or above the price you paid
due to fluctuations in the market price of our common stock caused by changes in our operating
performance or prospects and other factors.
Some specific factors that may have a significant effect on our common stock market price
include:
•
actual or anticipated quarterly fluctuations in our operating and financial
results;
•
the success of competitive service offerings or technologies;
•
the timing of announcements in the public market regarding new products, product
enhancements or technological advances by our competitors or us;
•
any announcements by us or our competitors of acquisitions, major transactions,
or management changes;
•
speculation in the press and the analyst community, including with respect to
Comverse's strategic plans;
•
announcements relating to Comverse's strategic plans;
4
Table of Contents
•
changes in recommendations or earnings estimates by financial analysts;
•
changes in investors' or analysts' valuation measures for our stock;
•
our credit ratings;
•
market trends unrelated to our performance;
•
stock sales by Comverse or our directors, officers, or other significant
holders;
•
developments related to investigations, proceedings, or litigation that involve
us;
•
regulatory developments; and
•
developments related to the industries in which we compete.
A significant drop in our stock price could also expose us to the risk of securities class
actions lawsuits, which could result in substantial costs and divert management's attention and
resources, which could adversely affect our business.
Because our common stock has been re-listed on the NASDAQ Global Market only since July 6,
2010, we cannot predict the extent to which investor interest in our company will lead to the
development of an active trading market on the NASDAQ Global Market or otherwise or how liquid that
market might become. Unless there is an active trading market for our common stock, you may have
difficulty selling any shares of our common stock that you purchase. Consequently, you may not be
able to sell our common stock at prices equal to or greater than the price you paid.
Sales or potential sales of our common stock by us or our significant stockholders may cause the
market price of our common stock to decline.
We are not restricted from issuing additional shares of common stock, including shares
issuable pursuant to securities that are convertible into or exchangeable for, or that represent
the right to receive, common stock. As of March 23, 2011, we had 37.1 million shares of common
stock outstanding. In addition, as of that date, approximately 4.0 million shares of our common
stock (including the 35,815 shares included in this prospectus, which were acquired by the selling
stockholders on April 10, 2011) were issuable pursuant to outstanding stock options and awards
which had not yet vested or which had been previously acquired upon vesting but had not yet been
delivered. Additional shares of common stock are also available to be granted under our existing
equity plans or may be granted under future equity plans. In addition, under two registration
rights agreements that we entered into with Comverse, Comverse has registration rights with respect
to its common stock and preferred stock holdings in Verint. As of January 31, 2011, the preferred
stock was convertible into approximately 10.4 million shares of our common stock. Stock sales by
Comverse or our directors, officers, or other significant holders may affect our stock price.
Anti-takeover provisions in Delaware corporate law may make it difficult for our stockholders to
replace or remove our current board of directors and could deter or delay third-parties from
acquiring us, which may adversely affect the marketability and market price of our common stock.
We are subject to the anti-takeover provisions of Section 203 of the Delaware General
Corporation Law. Under these provisions, if anyone becomes an "interested stockholder", we may not
enter into a "business combination" with that person for three years without special approval,
which could discourage a third party from making a takeover offer and could delay or prevent a
change of control. For purposes of Section 203, "interested stockholder" means, generally, someone
owning more than 15% or more of our outstanding voting stock or an affiliate of ours that owned 15%
or more of our outstanding voting stock during the past three years, subject to certain exceptions
as described in Section 203.
5
Table of Contents
Under any change of control, as defined in our credit agreement, the lenders under our credit
facility would have the right to require us to repay all of our outstanding obligations under the
facility. Upon the occurrence of a "Fundamental Change", as defined by the Certificate of
Designation setting forth the terms of the preferred stock, and which includes a change of control,
the holders of our preferred stock have the right to require us to repurchase their shares of
preferred stock at the then current liquidation preference (subject to certain exceptions set forth
in the Certificate of Designation).
Holders of our preferred stock have liquidation and other rights that are senior to the rights
of the holders of our common stock.
Our board of directors has the authority to designate and issue preferred stock that may have
dividend, liquidation and other rights that are senior to those of our common stock. As of January
31, 2011, 293,000 shares of our preferred stock have been issued and are outstanding. As of
January 31, 2011, the preferred stock was convertible into approximately 10.4 million shares of our
common stock. Holders of our preferred stock are entitled to cumulative dividends before any
dividends may be declared or set aside on our common stock. Upon our voluntary or involuntary
liquidation, dissolution or winding up, before any payment is made to holders of our common stock,
holders of our preferred stock are entitled to receive an initial liquidation preference of $1,000
per share, plus any accrued and unpaid dividends, which liquidation preference was approximately
$338.7 million in the aggregate as of January 31, 2011. This will reduce the remaining amount of
our assets, if any, available to distribute to holders of our common stock.
6
Table of Contents
USE OF PROCEEDS
We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The proceeds from the sale of the common stock
covered by this prospectus are solely for the accounts of the selling stockholders.
We will bear all costs, expenses and fees in connection with the registration of the shares.
Brokerage commissions and similar selling expenses, if any, attributable to the offer or sale of
the shares will be borne by the selling stockholders.
7
Table of Contents
SELLING STOCKHOLDERS
This prospectus relates to shares of our common stock previously issued pursuant to the Plans
to certain of our employees that are being registered for resale. All of the shares of common
stock that may be resold pursuant to this prospectus were previously acquired by the selling
stockholders upon the satisfaction of applicable vesting conditions relating to certain equity
awards (i.e., stockholder approval of a new equity compensation plan or our having additional share
capacity under one of our existing stockholder-approved equity compensation plans and/or the
passage of time).
The selling stockholders may resell any or all of such shares of common stock at any time they
choose while this prospectus is effective. The inclusion in this prospectus of the employees named
below who have acquired shares of our common stock under the Plans shall not be deemed to be an
admission that any such individual is an "affiliate" of ours. There is no assurance that any of
the selling stockholders will sell any or all of the shares of common stock covered by this
prospectus.
The following is a list of our employees, regardless of number of shares held, who previously
acquired shares of our common stock in connection with a vesting event that took place on April 10,
2011, pursuant to awards previously granted under the Plans, whose shares are being registered for
resale pursuant to this prospectus. These employees may sell up to an aggregate of 35,815 shares
of common stock, representing less than 1% of our issued and outstanding shares of common stock.
This percentage of ownership is based on 37,142,644 shares of our common stock issued and
outstanding as of March 23, 2011 plus an additional 289,930 shares of our common stock that were
acquired by our officers, directors and employees pursuant to vesting events occurring after that
date, including the 35,815 shares of our common stock that may be offered pursuant to this
prospectus that were acquired by the selling stockholders on April 10, 2011, for a total of
37,432,574 shares.
Eli Arman
Gabriel Horowitz
Carl David Robson
Sunil Aryan
Gary W. Humphrey
Bryan Melvyn Rose
Kar Ashutosh
Ron Jenik
Elizabeth Russell
Zwicka Ben Zion
Jay Jennings
William Ryan
Amy Blank
Jeff D. Jue
William D. Schneider
Katherine Bost
Steve Kaden
Omer Shavit
Jean Boudreau
Kevin Kurimsky
Jim Sherring
Richard Branchaud
Adam Wan Fung Kwok
Ziv Simhon
Josef Bronstein
Amanda Lewis
David Singer
Brian Carman
Michel J. Manche
Kevin J. Steel
Kenneth Carney
Mary Christine McAleer
David Stone
William Stuart Caton III
John McCourt
Ram Swery
Donna Colby
James Moretti
Guy Tamir
Sue Cordaro
Christopher Nelson
Matthew Paul Tengwall
Patrick Dagenais
Kasey Newman
Gary S. Trudo
Andrew Davies
Robert Nyberg
Daniel Vitlis
William L. Eckard III
Christopher Orr
Daniel Weiss
Charles Ehlers
Paul Patton
Timothy Wilkie
Karen Flynn
Jose Fortuna Penaredondo
Jon Wilson
Michael Gagnon
Colin Maurice Pope
Alexander Zur
Siddartha Gandhi
Sean Quigley
Andrew Robert Hawkes
Matthew Robson
8
Table of Contents
PLAN OF DISTRIBUTION
The selling stockholders have not advised us of any specific plan for the sale or distribution
of the shares of common stock covered by this prospectus. If and when they occur, such sales may
be made in any of the following manners:
•
on the NASDAQ Global Market (or through the facilities of any national
securities exchange or U.S. inter-dealer quotation system of a registered national
securities association on which shares of our common stock are then listed,
admitted to unlisted trading privileges or included for quotation);
•
in public or privately negotiated transactions;
•
in transactions involving principals or brokers;
•
in a combination of such methods of sale; or
•
any other lawful methods.
Although sales of the shares of common stock covered by this prospectus are, in general,
expected to be made at market prices prevailing at the time of sale, the shares may also be sold at
prices related to such prevailing market prices or at negotiated prices, which may differ
considerably.
When offering the shares of common stock covered by this prospectus, each of the selling
stockholders and any broker-dealers who sell the shares for the selling stockholders may be
"underwriters" within the meaning of the Securities Act, and any profits realized by such selling
stockholders and the compensation of such broker-dealers may be underwriting discounts and
commissions.
Sales through brokers may be made by any method of trading authorized by any stock exchange or
market on which our common stock may be listed, including block trading in negotiated transactions.
Without limiting the foregoing, such brokers may act as dealers by purchasing any or all of the
shares of common stock covered by this prospectus, either as agents for others or as principals for
their own accounts, and reselling such shares pursuant to this prospectus. The selling
stockholders may effect such transactions directly, or indirectly through underwriters,
broker-dealers or agents acting on their behalf. In connection with such sales, such
broker-dealers or agents may receive compensation in the form of commissions, concessions,
allowances or discounts, any or all of which might be in excess of customary amounts.
Each of the selling stockholders is acting independently of us in making decisions with
respect to the timing, manner and size of each sale of shares. We have not been advised of any
definitive selling arrangement at the date of this prospectus between any selling stockholder and
any broker-dealer or agent.
To the extent required, the names of any agents, broker-dealers or underwriters and applicable
commissions, concessions, allowances or discounts, and any other required information with respect
to any particular offer of the shares by the selling stockholders, will be set forth in a
prospectus supplement.
The expenses of preparing and filing this prospectus and the related registration statement
with the SEC will be paid entirely by us. The selling stockholders have been advised that they are
subject to the applicable provisions of the Exchange Act, including without limitation Rule 10b-5
thereunder.
Neither we nor the selling stockholders can currently estimate the amount of commissions or
discounts, if any, that will be paid by the selling stockholders on account of their sales of the
shares from time to time.
9
Table of Contents
LEGAL MATTERS
The validity of the issuance of the shares of common stock offered in this prospectus will be
passed upon for us by Jones Day, New York, New York.
EXPERTS
The consolidated financial statements, incorporated in this prospectus by reference from
Verint Systems Inc.'s Annual Report on Form 10-K for the year ended January 31, 2011, and the
effectiveness of Verint Systems Inc.'s internal control over financial reporting as of January 31,
2011 have been audited by Deloitte & Touche LLP, an independent registered public accounting firm,
as stated in their reports, which are incorporated herein by reference. Such consolidated financial
statements have been so incorporated in reliance upon the reports of such firm given upon their
authority as experts in accounting and auditing.
INFORMATION INCORPORATED BY REFERENCE
The SEC allows us to incorporate by reference certain of our publicly filed documents into
this prospectus, which means that we can disclose important business and financial information to
you that is not included in or delivered with this prospectus by referring you to publicly filed
documents that contain the omitted information. The information incorporated by reference is
considered to be part of this prospectus, and any later information that we file with the SEC will
automatically update and supersede this information. You will be deemed to have notice of all
information incorporated by reference into this prospectus as if that information were included in
this prospectus.
The following documents that we have filed with the SEC are incorporated herein by reference:
•
our Annual Report on Form 10-K for the year ended January 31, 2011, filed with
the SEC on April 6, 2011;
•
our Current Reports on Form 8-K, filed with the SEC on March 3, 2011 and March
30, 2011; and
•
the description of our common stock, par value $0.001 per share, contained in
our Registration Statement on Form 8-A, filed with the SEC on July 2, 2010.
Except as otherwise indicated, all documents we file with the SEC pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the
filing of a post-effective amendment that indicates that all securities offered have been sold or
that deregisters all securities then remaining unsold will be deemed to be incorporated by
reference into this prospectus and to be part hereof from the date of filing of such documents.
Any statement contained in any document incorporated or deemed to be incorporated by reference
herein will be deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained herein or in any other subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded will not be deemed, except as modified or superseded, to
constitute a part of this prospectus. This prospectus is part of a Registration Statement on Form
S-8 that we filed with the SEC and does not contain all of the information set forth in that
Registration Statement.
We will provide, free of charge, to any person to whom a copy of this prospectus is delivered,
upon written or oral request, a copy of any or all of the documents incorporated by reference into
this prospectus, other than exhibits to those documents unless specifically incorporated by
reference. To request a copy of those documents, you should contact us as set forth below under
"Where You Can Find Additional Information."
10
Table of Contents
WHERE YOU CAN FIND ADDITIONAL INFORMATION
We file annual, quarterly and current reports, proxy statements, and other information with
the SEC. The SEC allows us to incorporate by reference the information we file with it, which
means that we can disclose important business and financial information to you that is not included
in or delivered with this prospectus by referring you to publicly filed documents that contain the omitted information. We provide a
list of all documents we incorporate by reference into this prospectus under "Information
Incorporated by Reference" above.
Through our website at www.verint.com, we make available the information that we incorporate
by reference into this prospectus, as well as other reports, proxy statements, and other
information that we file with the SEC. You may also read and copy those materials at the SEC's
Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at (800)
SEC-0330 for further information on the operation of the Public Reference Room. In addition, we
are required to file electronic versions of those materials with the SEC through the SEC's EDGAR
system. The SEC maintains a website at www.sec.gov that contains reports, proxy statements, and
other information that registrants, such as we, file electronically with the SEC. Our website
address set forth above is not intended to be an active link, and information on our website is not
incorporated in, and should not be construed to be a part of, this prospectus.
Each person to whom a prospectus is delivered may also request a copy of those materials, free
of charge, by contacting us at:
Verint Systems Inc.
330 South Service Road
Melville, New York 11747
(631) 962-9600
Attn: Corporate Secretary
11
Table of Contents
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents filed by the Company with the Commission are incorporated herein by
reference:
•
the Company's Annual Report on Form 10-K for the year ended January 31, 2011, filed
with the Commission on April 6, 2011;
•
the Company's Current Reports on Form 8-K, filed with the Commission on March 3,
2011 and March 30, 2011; and
•
the description of the Company's common stock, par value $0.001 per share, contained
in the Company's Registration Statement on Form 8-A, filed with the Commission on July
2, 2010.
All documents filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14
and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), subsequent to
the date of this Registration Statement and prior to the filing of a post-effective amendment that
indicates that all securities offered have been sold or which deregisters all securities then
remaining unsold will be deemed to be incorporated by reference in this Registration Statement and
to be part hereof from the date of filing of such documents. Any statement contained in any
document incorporated or deemed to be incorporated by reference herein will be deemed to be
modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so
modified or superseded will not be deemed, except as modified or superseded, to constitute a part
of this Registration Statement.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
Not applicable.
Item 6.
Indemnification of Directors and Officers.
Section 102 of the General Corporation Law of the State of Delaware, or the DGCL, permits a
corporation to eliminate the personal liability of directors of a corporation to the corporation or
its stockholders for monetary damages for a breach of fiduciary duty as a director, except where
the director breached his duty of loyalty, failed to act in good faith, engaged in intentional
misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock
repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our
amended and restated certificate of incorporation provides that none of our directors shall be
personally liable to Verint or our stockholders for monetary damages for any breach of fiduciary
duty as a director, except (i) for any breach of the director's duty of loyalty to Verint or its
stockholders, or (ii) for acts or omissions which are not taken or omitted to be taken in good
faith or which involve intentional misconduct or knowing violation of the law, or (iii) for any
matter in respect of which such director shall be liable under Section 174 of Title 8 of the DGCL
or any amendment or successor provision thereto, or (iv) for any transaction from which the
director shall have derived an improper personal benefit.
Section 145 of the DGCL provides that a corporation has the power to indemnify a director,
officer, employee, or agent of the corporation, or a person serving at the request of the
corporation for another corporation, partnership, joint venture, trust or other enterprise in
related capacities, against expenses (including attorneys' fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by the person in connection with an action, suit or
proceeding to which he was or is a party or is threatened to be made a party to any threatened,
ending or completed action, suit or proceeding by reason of such position, if such person acted in
good faith and in a
manner he reasonably believed to be in or not opposed to the best interests of the
corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his
conduct was unlawful, except that, in the case of actions brought by or in the right of the
corporation, no indemnification shall be made with respect to any claim, issue or matter as to
which such person shall have been adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or other adjudicating court determines that, despite the
adjudication of liability but in view of all of the circumstances of the case, such person is
fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such
other court shall deem proper.
II-1
Table of Contents
Our certificate of incorporation provides that every person who is or was our director,
officer, employee or agent or is or was a director, officer, trustee, employee or agent of any
other enterprise, serving as such at our request, shall be indemnified to the fullest extent
permitted by law for all expenses and liabilities in connection with any proceeding involving such
person in this capacity. We entered into an indemnification agreement with each of our directors
and officers under which we agreed to provide indemnification and expense reimbursement as outlined
above.
Each of our directors who is also a director and/or officer of Comverse has an indemnification
agreement with Comverse. Under this agreement, Comverse has agreed to indemnify such person
against losses and expenses, to the extent permitted by law, incurred by such person in connection
with his service as director and/or officer of Comverse or any of its subsidiaries.
Item 7.
Exemption from Registration Claimed.
As previously disclosed, as a result of the Company's inability to file required reports with
the Commission during the Company's extended filing delay period, the Company previously ceased
using its existing registration statements on Form S-8 to make equity grants to employees. On May
24, 2007, the Company received a no-action letter from the Commission upon which the Company relied
to make broad-based equity grants to employees under a no-sale theory. The Company has also made
equity grants to certain employees in transactions that did not involve public offerings and that
were exempt from registration under the Securities Act of 1933 under Section 4(2) of and/or
Regulation D and/or Regulation S under the Securities Act of 1933. All of the shares of common
stock that may be offered pursuant to this registration statement were acquired by the selling
stockholders upon the grant of restricted stock pursuant to an applicable exemption from the
registration requirements of the Securities Act of 1933 or the vesting of equity awards issued
pursuant to the no-sale theory or an applicable exemption from registration.
Item 8.
Exhibits.
Filed Herewith /
Incorporated by Reference
Number
Description
from
3.1
Amended and Restated Certificate of Incorporation of Verint Systems Inc.
Form S-1 (Commission File No.
333-82300) effective on May 16,
2002
3.2
Certificate of Designation, Preferences and Rights of the Series A
Convertible Perpetual Preferred Stock
Form 8-K filed on May 30, 2007
3.3
Amended and Restated By-laws of Verint Systems Inc.
Form 8-K filed on January 7, 2011
4.1
Specimen Common Stock certificate
Form S-1 (Commission File No.
333-82300) effective on May 16,
2002
4.2
Specimen Series A Convertible Perpetual Preferred Stock certificate
Form 10-K filed on March 17, 2010
4.3
Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as amended
and restated
Form 8-K filed on January 10, 2006
4.4
Amendment No. 1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December 23, 2008)
Form 10-K filed on March 17, 2010
4.5
Witness Systems Amended and Restated Stock Incentive Plan
Witness Systems, Inc. Form 10-Q
filed on August 9, 2005
II-2
Table of Contents
Filed Herewith /
Incorporated by Reference
Number
Description
from
4.6
Amendment No. 1 to Witness Systems Amended and Restated Stock Incentive
Plan (dated May 29, 2001)
Witness Systems, Inc. Form 10-K
filed on March 17, 2006
4.7
Amendment No. 2 to Witness Systems Amended and Restated Stock Incentive
Plan (dated January 15, 2004)
Witness Systems, Inc. Form 10-K
filed on March 15, 2004
4.8
Amendment No. 3 to Witness Systems Amended and Restated Stock Incentive
Plan (dated December 6, 2007)
Form 10-K filed on March 17, 2010
4.9
Amendment No. 4 to Witness Systems Amended and Restated Stock Incentive
Plan (dated December 23, 2008)
Form 10-K filed on March 17, 2010
5.1
Opinion of Jones Day
Filed Herewith
23.1
Consent of Deloitte & Touche LLP
Filed Herewith
23.2
Consent of Jones Day (included in Exhibit 5.1)
Filed Herewith
Item 9.
Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) to reflect in the prospectus any facts or events arising after the effective date
of this registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this registration statement; and
(iii) to include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such
information in this registration statement;
provided, however
, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the registration
statement is on Form S-8, and the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Commission by the
Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by
reference in this registration statement.
II-3
Table of Contents
(2) That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time will be deemed to be
the initial
bona fide
offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act, each filing of the Registrant's annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this registration statement will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that
time will be deemed to be the initial
bona fide
offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with
the securities being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
II-4
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the city of Melville, State of New York, on this 11th day of April,
2011.
VERINT SYSTEMS INC.
By:
/s/ Dan Bodner
Dan Bodner
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
been signed by the following persons in the capacities and on the dates indicated.
/s/ Dan Bodner
Dan Bodner, Chief Executive Officer and President;
Director of Verint Systems Inc.
(Principal Executive Officer)
April 11, 2011
/s/ Douglas E. Robinson
Douglas E. Robinson, Chief Financial Officer of Verint Systems Inc.
(Principal Financial Officer and Principal Accounting Officer)
April 11, 2011
/s/ Paul D. Baker
Paul D. Baker, Director of Verint Systems Inc.
April 11, 2011
/s/ John Bunyan
John Bunyan, Director of Verint Systems Inc.
April 11, 2011
/s/ Charles J. Burdick
Charles J. Burdick, Director of Verint Systems Inc.
April 11, 2011
/s/ Victor A. DeMarines
Victor A. DeMarines, Director of Verint Systems Inc.
April 11, 2011
/s/ Larry Myers
Larry Myers, Director of Verint Systems Inc.
April 11, 2011
/s/ Howard Safir
Howard Safir, Director of Verint Systems Inc.
April 11, 2011
/s/ Shefali Shah
Shefali Shah, Director of Verint Systems Inc.
April 11, 2011
II-5
Table of Contents
EXHIBIT INDEX
Filed Herewith /
Incorporated by Reference
Number
Description
from
3.1
Amended and Restated Certificate of Incorporation of Verint
Systems Inc.
Form S-1 (Commission
File No. 333-82300)
effective on May 16,
2002
3.2
Certificate of Designation, Preferences and Rights of the Series A
Convertible Perpetual Preferred Stock
Form 8-K filed on May
30, 2007
3.3
Amended and Restated By-laws of Verint Systems Inc.
Form 8-K filed on
January 7, 2011
4.1
Specimen Common Stock certificate
Form S-1 (Commission
File No. 333-82300)
effective on May 16,
2002
4.2
Specimen Series A Convertible Perpetual Preferred Stock certificate
Form 10-K filed on March
17, 2010
4.3
Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended and restated
Form 8-K filed on
January 10, 2006
4.4
Amendment No. 1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December 23,
2008)
Form 10-K filed on March
17, 2010
4.5
Witness Systems Amended and Restated Stock Incentive Plan
Witness Systems, Inc.
Form 10-Q filed on
August 9, 2005
4.6
Amendment No. 1 to Witness Systems Amended and Restated Stock
Incentive Plan (dated May 29, 2001)
Witness Systems, Inc.
Form 10-K filed on March
17, 2006
4.7
Amendment No. 2 to Witness Systems Amended and Restated Stock
Incentive Plan (dated January 15, 2004)
Witness Systems, Inc.
Form 10-K filed on March
15, 2004
4.8
Amendment No. 3 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December 6, 2007)
Form 10-K filed on March
17, 2010
4.9
Amendment No. 4 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December 23, 2008)
Form 10-K filed on March
17, 2010
5.1
Opinion of Jones Day
Filed Herewith
23.1
Consent of Deloitte & Touche LLP
Filed Herewith
23.2
Consent of Jones Day (included in Exhibit 5.1)
Filed Herewith